Long-Term Safety and Efficacy of Depemokimab in Patients with Type 2 Asthma: A Single-Arm, Open-Label Extension Study (AGILE)

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Michael Wechsler, Paul Pfeffer, David Bernstein, Ruchong Chen, Toshiyuki Koya, David Jackson, Ian D. Pavord, David Muccino, Chang-Qing Zhu, Sarah West, Peter Howarth, Daniel Jackson
DOI: 10.1016/j.jaci.2025.12.831
Cited by: 3

Fields of Study & Subjects

Asthma and respiratory diseases Dermatology and Skin Diseases Drug-Induced Adverse Reactions

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Volume
157
Issue
2
Pages
AB278–AB278
Publication date
1 February 2026
Language
EN